NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,377.98 +170.85 (+0.94%) CRUDE OIL
79.15 +0.20 (+0.25%) GOLD FUTURES
2,309.50 -0.10 (-0.00%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,672.11 +1,832.47 (+4.00%)
Ainos, Inc. (AIMD)
After hours:
| Previous close | 1.0500 |
| Open | 1.0398 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.0156 - 1.0700 |
| 52-week range | 0.7900 - 6.1000 |
| Volume | |
| Avg. volume | 1,412,386 |
| Market cap | 6.39M |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small-Cap Growth Virtual Investor Conference held February 7th are now available for online viewing. REGISTER NOW AT: https://bit.ly/3SOf3yh The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may
- GlobeNewswire
Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Small-Cap Growth Virtual Investor Conference to be held February 7th, 2024. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3SGVqItIt is recommended that investors pre-reg
- GlobeNewswire
Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comSAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that Jack Lu, the Company’s Director of Corporate
